Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease
- PMID: 8030754
- PMCID: PMC1887290
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease
Abstract
Heme oxygenase-1 is an important enzyme that degrades heme, a pro-oxidant, leading to the formation of antioxidant molecules. In this study we demonstrate by immunocytochemistry close association of heme oxygenase-1 with Alzheimer neurofibrillary pathology and with the neurofibrillary tangles found in progressive supranuclear palsy and subacute sclerosing panencephalitis. In Alzheimer's disease, using two different rabbit antisera against heme oxygenase-1 protein, we localized, using immunocytochemical methods, heme oxygenase-1 to neurofibrillary tangles, senile plaque neurites, granulovacuolar degeneration, and neuropil threads. Only light background staining was seen in young controls and sporadic lesion-related immunoreactivity in age-matched controls. The increase in heme oxygenase-1 protein in association with the neurofibrillary pathology of Alzheimer's disease and other diseases characterized by neurofibrillary tangles supports the notion that the generation of free radicals and oxidative stress plays a role in the pathogenesis of neurofibrillary pathology.
Similar articles
-
Ultrastructural localization of heme oxygenase-1 to the neurofibrillary pathology of Alzheimer disease.Mol Chem Neuropathol. 1995 Feb-Apr;24(2-3):227-30. doi: 10.1007/BF02962147. Mol Chem Neuropathol. 1995. PMID: 7632324 No abstract available.
-
Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain.Ann Neurol. 1995 Jun;37(6):758-68. doi: 10.1002/ana.410370609. Ann Neurol. 1995. PMID: 7778849
-
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.J Neurochem. 2001 Jan;76(2):435-41. doi: 10.1046/j.1471-4159.2001.00046.x. J Neurochem. 2001. PMID: 11208906
-
Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.Arzneimittelforschung. 1995 Mar;45(3A):403-9. Arzneimittelforschung. 1995. PMID: 7763334 Review.
-
Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.Curr Opin Psychiatry. 2008 Nov;21(6):555-61. doi: 10.1097/YCO.0b013e328314b78b. Curr Opin Psychiatry. 2008. PMID: 18852562 Review.
Cited by
-
Dysregulation of a Heme Oxygenase-Synuclein Axis in Parkinson Disease.NeuroSci. 2022 May 20;3(2):284-299. doi: 10.3390/neurosci3020020. eCollection 2022 Jun. NeuroSci. 2022. PMID: 39483365 Free PMC article. Review.
-
Exploring the potential mechanism of atrazine-induced dopaminergic neurotoxicity based on integration strategy.Environ Health Prev Med. 2024;29:46. doi: 10.1265/ehpm.24-00079. Environ Health Prev Med. 2024. PMID: 39231689 Free PMC article.
-
Behavioral and histological assessment of a novel treatment of neuroHIV in humanized mice.Res Sq [Preprint]. 2023 Dec 13:rs.3.rs-3678629. doi: 10.21203/rs.3.rs-3678629/v1. Res Sq. 2023. PMID: 38168407 Free PMC article. Preprint.
-
Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus.Int J Mol Sci. 2023 Sep 22;24(19):14450. doi: 10.3390/ijms241914450. Int J Mol Sci. 2023. PMID: 37833898 Free PMC article. Review.
-
The Role of Heme and Copper in Alzheimer's Disease and Type 2 Diabetes Mellitus.JACS Au. 2023 Feb 17;3(3):657-681. doi: 10.1021/jacsau.2c00572. eCollection 2023 Mar 27. JACS Au. 2023. PMID: 37006768 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical